The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

R. Crocchiolo, L. Castagna, S. Furst, R. Devillier, B. Sarina, S. Bramanti, J. El-Cheikh, A. Granata, S. Harbi, L. Morabito, C. Faucher, A. Rimondo, D. Girardi, B. Mohty, B. Calmels, C. Carlo-Stella, C. Chabannon, R. Bouabdallah, A. Santoro, N. VeyP. J. Weiller, D. Blaise

Research output: Contribution to journalArticle

6 Citations (Scopus)
Original languageEnglish
JournalBone Marrow Transplantation
DOIs
Publication statusAccepted/In press - Mar 21 2016

ASJC Scopus subject areas

  • Hematology
  • Transplantation

Cite this

The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide. / Crocchiolo, R.; Castagna, L.; Furst, S.; Devillier, R.; Sarina, B.; Bramanti, S.; El-Cheikh, J.; Granata, A.; Harbi, S.; Morabito, L.; Faucher, C.; Rimondo, A.; Girardi, D.; Mohty, B.; Calmels, B.; Carlo-Stella, C.; Chabannon, C.; Bouabdallah, R.; Santoro, A.; Vey, N.; Weiller, P. J.; Blaise, D.

In: Bone Marrow Transplantation, 21.03.2016.

Research output: Contribution to journalArticle

Crocchiolo, R, Castagna, L, Furst, S, Devillier, R, Sarina, B, Bramanti, S, El-Cheikh, J, Granata, A, Harbi, S, Morabito, L, Faucher, C, Rimondo, A, Girardi, D, Mohty, B, Calmels, B, Carlo-Stella, C, Chabannon, C, Bouabdallah, R, Santoro, A, Vey, N, Weiller, PJ & Blaise, D 2016, 'The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide', Bone Marrow Transplantation. https://doi.org/10.1038/bmt.2016.69
Crocchiolo, R. ; Castagna, L. ; Furst, S. ; Devillier, R. ; Sarina, B. ; Bramanti, S. ; El-Cheikh, J. ; Granata, A. ; Harbi, S. ; Morabito, L. ; Faucher, C. ; Rimondo, A. ; Girardi, D. ; Mohty, B. ; Calmels, B. ; Carlo-Stella, C. ; Chabannon, C. ; Bouabdallah, R. ; Santoro, A. ; Vey, N. ; Weiller, P. J. ; Blaise, D. / The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide. In: Bone Marrow Transplantation. 2016.
@article{037f560796154d9ba9c5b10978c3d5d9,
title = "The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide",
author = "R. Crocchiolo and L. Castagna and S. Furst and R. Devillier and B. Sarina and S. Bramanti and J. El-Cheikh and A. Granata and S. Harbi and L. Morabito and C. Faucher and A. Rimondo and D. Girardi and B. Mohty and B. Calmels and C. Carlo-Stella and C. Chabannon and R. Bouabdallah and A. Santoro and N. Vey and Weiller, {P. J.} and D. Blaise",
year = "2016",
month = "3",
day = "21",
doi = "10.1038/bmt.2016.69",
language = "English",
journal = "Bone Marrow Transplantation",
issn = "0268-3369",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The patient’s CMV serological status affects clinical outcome after T-cell replete haplo-HSCT and post-transplant cyclophosphamide

AU - Crocchiolo, R.

AU - Castagna, L.

AU - Furst, S.

AU - Devillier, R.

AU - Sarina, B.

AU - Bramanti, S.

AU - El-Cheikh, J.

AU - Granata, A.

AU - Harbi, S.

AU - Morabito, L.

AU - Faucher, C.

AU - Rimondo, A.

AU - Girardi, D.

AU - Mohty, B.

AU - Calmels, B.

AU - Carlo-Stella, C.

AU - Chabannon, C.

AU - Bouabdallah, R.

AU - Santoro, A.

AU - Vey, N.

AU - Weiller, P. J.

AU - Blaise, D.

PY - 2016/3/21

Y1 - 2016/3/21

UR - http://www.scopus.com/inward/record.url?scp=84961393842&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84961393842&partnerID=8YFLogxK

U2 - 10.1038/bmt.2016.69

DO - 10.1038/bmt.2016.69

M3 - Article

AN - SCOPUS:84961393842

JO - Bone Marrow Transplantation

JF - Bone Marrow Transplantation

SN - 0268-3369

ER -